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The dangers of ‘splicing and dicing’: on the use 
of chimeric transcriptional activators in vitro 
Chimeric transcription factors composed of heterologous DNA-binding and activation 
domains are often used to study the regulation of gene expression. The fact that 
such preparations also contain molecules in which only one of the two 
domains is functional is often overlooked, but a surprisingly small 
proportion of inactive domains could cause serious problems 
in the interpretation of quantitative data. 
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Understanding the molecular mechanisms involved in 
the regulation of eukaryotic gene expression is a central 
problem in molecular biology. In most cases, regulation 
occurs at the level of transcription. Not only is the 
proper regulation of RNA biosynthesi< central to 
development and the appropriate response of cells to 
metabolic signals, but it is now clear that many human 
cancerc immlve aberrant gene regulation.The transcrip- 
tion of almost all genes is controlled, at Icast in part. by 
gene-specitic activators.This ubiquitous class of proteins 
can stimulate the transcription of target genes by 
1 OOO-fold or more in response to the appropriate signal. 
No one knows exactly how activators bring about this 
huge increase in the tii-equency of transcript synthesis, 
but qonle commonalitirs between the hundreds of acti- 
vators characterized to date have become clear. Most 
importantly, activators must both contact specific DNA 
sequences in the target promoter and bind other tran- 
cription factors, including one or morr proteins in the 
general transcription complex. Several years ago it was 
dmlonstrated that these activities reside on domains that 
art‘ separable and functionally independent [l--l]. A par- 
ticularly Ftriking demonstration of this was the finding 
that chjrneric transcription factors composed of I)NA- 
binding domains from one protein and protein-interac- 
tion (activation) domains from another could activate 
transcription irr ~itr.o and to some extent irr viva [5,61. 
lkcause the functions of the two domains are separable, 
ho\vrvcr, they can also be inactivated separately. This can 
pose problems when mixtures of fully and partially 
active chimeric activators are used to study activator 
fLiiictioii if/ rGtr0. 
Activators bind to DNA sites far from the transcription 
start site 
The binding sites for activators and for the genera1 trans- 
cription machinery are usually separated by hundreds or 
thoumlds of‘ base pairs in natural promoters. Therefore, 
interactions between activators and the proteins respon- 
cible for transcription require ‘looping’ of the intervening 
DNA (Fig. 1) to bring the proteins close enough to bind. 
Although there is a general commsus in the transcription 
community that the looping model [7] is basically 
correct, it is now appreciated that the events involved are 
far more complex than this simple picture would suggest. 
For example, the stability of this looped complex may be 
affected by DNA-bending or wrapping proteins such as 
histones, providing yet another layer of control [S]. Even 
more problematic is that proteins known as coactivators 
are required to generate d response to activators irl vitro 
19-l 31, One well characterized coactivator, the SUGl 
protein of Sarr/2avc,,ny~f,s cenuisiac [ 14,151, resides in a large 
(-1000 kL)) complex that includes about 19 other pro- 
teins and has an ATPase activity that is required for high- 
level transcription [IC,] (R. Kornberg and colleagues, 
personal co~~~~nunication). Despite the complexity of the 
phenomenon, a central near-term goal in this area is rela- 
tively simple: it is to identie the protein-protein contacts 
between activators and other transcription factors, and 
the order in which they occur, so as to build up a picture 
of how a functional complex assembles. 
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Fig. 1. Activation of transcription requires DNA looping. The acti- 
vator binds to a specific DNA sequence (the enhancer) upstream 
of the transcription start site. For activation of transcription to 
occur, the DNA must form a ‘loop’ so that the activator is close 
enough to the transcription start site to form specific 
protein-protein contacts with the transcription complex bound 
there. After binding, DNA melting occurs and the transcription 
complex can initiate synthesis of mRNA. 
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Fig. 2. Several steps in the formation of an active transcription 
complex might be accelerated by activator binding. The first step 
in complex formation may be binding of the transcription factor 
TFIID to the TATA region of the promoter, followed by formation 
of the pre-initiation complex (PIG) and ATP-dependent melting of 
the DNA helix, after which transcription can begin. Activators 
might also enhance release of the polymerase from the promoter, 
a step which results in phosphorylation of the polymerase. 
Studying activator function 
It is generally assumed that activators (in concert with 
the appropriate coactivators) accelerate an otherwise 
rate-limiting step in the transcription cycle. The rate- 
limiting step has not been identified, but possible target 
steps include association of RNA polymerase and 
various general transcription factors [17] with the pro- 
moter to form a pre-initiation complex (PIC), melting of 
the double helix in the promoter region to allow associa- 
tion of the polymerase with the coding strand, and 
release of the polymerase from the promoter to allow 
elongation of the transcript (Fig. 2).The most straightfor- 
ward way to test these possibilities is to set up an irl vitro 
system that will allow the rate or equilibrium constant of 
any particular step to be measured in the presence and 
absence of an activator. In practice, this biochemical 
approach is fraught with technical problems, not the least 
of which is that native activators tend to be large, poorly 
behaved proteins that are very difficult to purify in rea- 
sonable quantities. This unfortunate property has led to 
the almost exclusive use of artificial chimeric activators 
for detailed in I&L) investigations. Particularly popular are 
species composed of the dimeric GAL4 DNA-binding 
domain (consisting of the amino-terminal -100 residues 
of this 881 amino acid protein) [18,19] fused to activa- 
tion domains from other transcription f&tors, such as the 
herpes simplex virus VP16 transactivator 1201. These 
chimeras are generally highly soluble and can be easily 
purified in milligram quantities. 
When used appropriately, chimeric activators are useful 
tools. But as they are artificial constructs composed of 
completely unrelated domains, they represent extreme 
examples of multifunctional proteins. A central charac- 
teristic that distinguishes such chimeras from simple 
monofunctional proteins with a single globular domain 
is that purified preparations of chimeric activators are 
likely to contain significant quantities of partially active 
molecules, proteins that bind DNA but do not activate 
and vilr VCYSU. The consequences of this simple fact are 
potentially quite profound, yet are often ignored. 
Composition of chimeric activator preparations 
Proteins can suffer any number of debilitating reactions 
during the course of purification and storage, including 
denaturation and/or chemical modification of various 
amino-acid side chains [Zl]. Many of these processes can 
abolish activity without obviously changing the chro- 
matographic properties of the protein or its elec- 
trophoretic behavior in denaturing gels. Thus, even 
preparations that appear as a single band on a gel may be 
composed of a heterogeneous collection of species, only 
some of which are active. Before the advent of recombi- 
nant-DNA technology, most proteins were purified on 
the basis of some biochemical activity, so that prepara- 
tions could reasonably be assumed to have a high ratio of 
active to inactive proteins. Nowadays, however, many 
recombinant proteins are expressed at high levels in 
Erckevickia co/i and their purification is monitored by gel 
electrophoresis. These preparations may well contain a 
significant fraction of inactive molecules. This may not 
be a problem, even in some quantitative studies, so long 
as the fraction of active protein is known and the inactive 
protein does not interfere with the active species.This is 
often the case with monofunctional globular proteins. 
Unfortunately, the situation is not so simple for multi- 
domain proteins. Since the heterologous DNA-binding 
and activation domains do not interact with one another 
in a functional or structural sense, it is reasonable to 
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Fig. 3. The sixteen possible dimeric 
species present in a purified prepara- 
tion of a dimeric activator of the type 
DBD-AD, divided into functional 
classes. The dark shaded domains are 
those that have been inactivated. We 
have calculated the relative representa- 
tion of each species, using x and y to 
represent the fraction of active DNA- 
Ibinding and activation domains, 
respectively. We have assumed that 
there is no resolution of the various 
species during purification, that both 
DNA-binding domains need to be 
active for the protein to bind to DNA, 
and that both activation domains are 
required for high-level transcriptional 
activation. The fraction of the total 
population that falls into each func- 
tional class, using these assumptions, is 
given. If only one of either type of 
domain is required for the function in 
qwstion, the argument elaborated in 
thr> remainder of this article is quantita- 
tively different, but the conclusions are 
essentially the same. 
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aswnle that a purified preparation of chimeric activator 
could contain, in addition to the completely active and 
inactive species, n~olecules that are competent for DNA 
binding but not activation, and molecules that cannot 
bind DNA. but contain a functional activation domain. 
To understand the consequences of this potential hetero- 
geneity, let us consider the possible composition of 
chimeric activator preparations. Figure 3 illustrates the 
sixteen dimeric species that may be contained in a prepa- 
ration of a chirneric activator such as GAL+VP16, which 
contains a DNA-binding domain (DBl>) fused to an acti- 
vation domain (AD). III our model, \ve have made the 
simplifying assumption that all of the molecules in the 
preparation are dimeric. If a third variable for dimerization 
actwlt)l were included it xvould alter the details of our dis- 
cussion, but would not affect the fundamental conclusions. 
The equations derived in Figure 3 can be used to calculate 
the relative amounts of the fully functional, DNA- 
binding and activation-competent species. In Figure 4, the 
rsprcted representation of each species is sho\vn for 
several values of the fraction of active IINA-binding (x) 
and activation (y) domains. 
As can be seen from Figure 4, even modest levels of inacti- 
vation of the DNA-binding or activation domains can lead 
to a preparation in which the completely active species 
comprises a minority of the population; the curve in 
Figure la is very steep. More importantly, it is clear that for 
certain values of-s and y, the two partially active spwies, 
I>B+/act~ and db-/ACT+. are present in excess over the 
fully fimctional chimera. For example, ifs = y = 0.5, thv 
ratio of l>B+/act- dinxm to IIU+/ACT’ tnolecule~ is 3: I, 
Obviously. this cm have important cc~t~scquc~~ces for the 
number of productiw complexes formed. bec~usc ofcom- 
petition. This reduction of @al to noise muuld not be 
serious if the unproductive complexes nere fiinctionall~ 
silent. Uut, as WC illustrate below: the prwmcc of such 
species may mull distort our \vholr picture of the 
activation process. 
The assembly of the general transcription complex 
Ow popular model for the mechanism of&on ofactiv,l- 
tors is that they bind stably to the enhmcer md accelerate 
the assembly of, and/or increase the stability of, the PIG. 
Since many biochcnkal pathways are regulated at an earl) 
step, it is particularly appealing to imagine that thr activk 
tor facilitates binding of the general transcriptioii fktor 
TFIIl> to the TATA region found in nlost promotcrc. as 
this sequence-specific IINA-binding event is thought to 
bc the first strp in the formation of the PlCThis model is 
consistent with the observation that the Alk of several 
activators bind the TATA-binding protein (THP) compo- 
nent of TFIID ill ICWO [ 23-211. Therefore, there has bren 
considrrable interest in probing the efkt of actiKxor\ on 
the prollloter-billdinS properties ofTHI’ 125.X]. 
In theory. this question cm be explored i11 1~ifr0 in a 
straightforward mmner. A DNA fragment containing 
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both an enhancer and a TATA box would be saturated 
with a purified chimeric activator. The thermodynamic 
and/or kinetic parameters of formation of the complex 
ofTUP with this activator-bound DNA would then be 
compared to those observed in a control experiment 
lacking the activator. Alternatively, the effect on some 
downstream event dependent on TBP-TATA associa- . 
tion, such as promoter un\vinding or pronloter-specific 
transcription, might be monitored in more complex 
assays that include other transcription factors. 
Data from such experiments are interpreted as if the 
only relevant equilibria that occur in solution are those 
shown in the shaded section of Figure 5.The problem is 
that both of the partially active chimeric ~nolecules are 
potential competitors. Thus, unless the chimera prepara- 
tion has a very low level of partially active ~~~olecules 
(x = y = 1, or nearly so), several other binding equilibria 
must be taken into account. Some examples are shown 
outside the box in Figure 5. For instance, if the prepara- 
tion contains a significant fraction of db-/ACT+ protein 
(x is small, y 1s 1 arge), then saturation of the enhancer 
will result in an excess of active ADS free in solution, 
which will compete with the enhancer-bound chimeras 
for TBP, forming species F (Fig. 5). Unless this complex 
can readily dissociate, which is by no means clear, these 
TBP molecules will be trapped in a form that cannot 
respond to DNA-bound activator. For example, 
complex F might first encounter the DB+/ACT+ 
chimera-DNA complex B to form complex G. This 
complex would be non-productive, and for this pro- 
moter to become functional one of two dissociation 
events would be necessary. Dissociation ofTUP from the 
db-/ACT+ chimera might occur, giving complex C; 
alternatively, TBP could dissociate from the TATA box, 
returning to complex B. Since many TBP-TATA corn- 
plexes have very long half-lives [27], this exchange 
might not occur on the time scale of the experiment. 
On the other hand, consider the situation in which a 
preparation containing a large amount of DB+/act- 
protein is employed (x is large, y is small). In this case, 
much of the DNA will be bound by an activator that 
cannot interact with TBP (complex E in Fig. 5). For 
example, if x = 0.8 and y = 0.3, then only 5.8 ‘26 of the 
DNAs will be occupied with chimeras capable of inter- 
acting with TBF? If the investigator assumes that the solu- 
tion contains a homogeneous population of DNA 
complexes, all of which are occupied by fully functional 
activators, even a large effect of the presence of the acti- 
vator on the properties of the TBP-TATA complex D 
could be missed. Because of these interfering side reac- 
tions it would be almost impossible to accurately 
measure the effect of the bound activator on the kinetic 
association and dissociation rates of the TBI’-TATA 
complex or its effect on thermodynamic equilibria. 
Chimeric activators in transcription reactions in vitro 
When probing for effects on TBP-TATA interactions, one 
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Fig. 4. Percentages of fully and partially active dimeric molecules 
in a dimeric activator population. (a) Fully active; (b) DB+/act-; 
(c) db-/ACT+. We have assumed for the purposes of these graphs 
that x and y are less than 0.9. 
activities, DNA binding and TBP binding.Thus the frac- 
tion of partially active molecules can in theory be deter- 
mined experimentally, and by using the appropriate 
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Fig. 5. Some of the equilibria that will 
occur when TATA-binding protein iTBPi 
is mixed with an excess of a chimeric 
activator and DNA containing an 
enhancer and a TATA region. The shaded 
box contains the binding events that are 
ideally the subject of the experiment. 
However, the events outside the box, as 
well as other equilibria not shown, must 
be taken into account ii using an activa- 
tor preparation that contains partially 
active species. DB+/act- proteins would 
compete for the DNA, forming complex 
E. Proteins that are db-/ACT+ would 
compete ior TBP, forming complex F, 
which could then compete for complex 
B to form complex G. Dark shaded 
domains are inactive. 
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affinity-purification protocols it may be possible to obtain 
a very high fraction of completely active tnolecules (see 
below). A far more difftcult situation arises when chimeric 
activators are employed in transcription reactions irr V~WO. 
Since it is unknown how an Al1 activates transcription, it 
is impossible to rigorously assay the fi-action of ACT+ 
species in a purified chimera preparation. Even if a prepa- 
ration is 90 74 active for TBP binding (or binding to any 
particular transcription factor), it is not clear that this 
means that 00 94 of the molecules are ACT+.The inability 
to know the &action ofACT+ ~nolecules in a preparation 
has significant practical consequences in the interpretation 
of i/l vitro transcription experiments. 
The iI1 IJ~WO experiments used to probe the molecular 
basis of the phenomenon of ‘synergistic activation’ are a 
case in point.The observation is that genes containing, for 
esanlple, two activator binding sites in the promoter are 
often espressed at a level much more than two-fold 
higher than a gene with a single enhancer [28-33].The 
molecular basis of this phenomenon is a very important 
issue in eukaryotic gene regulation, since most of the pro- 
moters contain binding sites for more than one activator. 
Our model that is frequently invoked (the ‘multiple- 
contact’ model) is that many specific interactions between 
the activator and the general transcription apparatus must 
be fulfilled in order to achieve high-level transcription, 
and that these cannot be saturated by ‘I single activator 
dimer [29,34]. Au alternative explanation would be that 
the activator does not saturate a single upstream site, but 
when more than ant‘ site is present cooperative DNA 
binding results in efficient occupation of the enhancer. In 
this view, only a single activator dimer would be required 
for high-level transcription [35], but binding is enhanced 
by the presence of other dinners. 
One imaginative ifl vitro experiment designed to dictin- 
guish between these possibilities employed chimeric 
GAL-I-VI’1 6 activators that contained either ant’, two or 
four AlIs fused to a single l>BlI [30]. The number of 
ADS delivered to the target promoter could thus be 
varied without changing the number of activator 
binding sites. In this system, if synergistic effects wert‘ 
observed they could not be ascribed to cooperative 
DNA binding. It was found that a GAL-I-VP16 dimer 
containing a total of four ADS activated transcription 
about five times as vvell as the standard dimeric 
GAL&VP1 6 chimera (two Al%) when an excess of the 
activator was added to an irl ~itrcl transcription system - 
a synergistic effect, apparently giving strong support to 
the multiple-contact model. But consideration of the 
potential effects of partially active chimeras in suc11 XI 
experiment suggests that another interpretation of these 
data is possible. 
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Using logic identical to that presented for the simple 
L1UI)-AD chimera, the frequency of the active and 
partially active DUI>-(AD), dimers expected to be 
present in a purified prepara;on can be calculated (Fig. 
6). We again assume that the fate of each domain is 
independent of the others and that all molecules are 
dimeric. Only the dimers that are active for DNA 
binding are depicted in thi5 case. 
One can use these equations, and the equations derived 
in Figure 3, to calculate the proportion of enhancer sites 
that are occupied with fully functional chimeras for 
each of the two populations (Fig. 7). Clearly, the propor- 
tion of sites productively occupied is higher for the 
1)BD-(AD)2 population than for the I>Bl)-AD popula- 
tion for identical values of y. This is a simple conse- 
quence of the fact that, all other things being equal, 
there is a much better chance that two out of four ADc 
per dimer will survive the purification protocol in active 
form than there is that two of two Al1s will retain activ- 
ity. The two species have the same number of DNA- 
binding domains, however, so the chances that the 
proteins will suffer loss of enhancer-binding activity are 
identical.Thus, the DHD-AD population should have a 
greater percentage of DB+/act- molecules than the 
DBD-(AD), population.This is of central importance if 
an excess of activator over DNA is employed. which is 
almost always the case. 
To compare the numbers more directly, we have plotted 
the ratio of DUD-(AD), DB+/ACT+ molecules to 
DBD-AD DB+/ACT+ molecules for various values of y 
(Fig. 8). It is clear that DBD-(AL)), chimeras can produce 
a much higher content of productively occupied tem- 
plates for some values of y. For example, if y = 0.2, there 
is a 4.5-fold difference between DBI1-(AI)), and 
DBE-AD, close to the experimental result of 5-fold 
increased activation. 
It is, indeed, quite possible that the conclusions originally 
drawn from this experiment are correct. If the DB’/act- 
species comprises a small fraction of both the DBD-AD 
and DBD-(AD). preparations (the value of y is high in 
each case), then -the published interpretation is correct. 
The important point, however. is that the value of y is 
unknowable, since there is no assay to distinguish active 
from inactive ADS. Therefore, it is impossible to com- 
pletely rule out ‘trivial’ interpretations of assays using 
Fig. 6. The five possible species compe- 
tent for DNA-binding present in a puri- 
fied preparation of a dimeric 
DBD-(AD)?-type activator, divided into 
functional classes. The dark shaded 
domains are those that have been inac- 
tivated. The relative representation of 
each species is shown below the 
chimera, using x and y to represent the 
fraction of active DNA-binding and acti- 
vation domains, respectively. We have 
assumed that there is no resolution of 
the various species during purification. 
novel chimeric activators.This experiment alone should 
not convince us that the multiple-contact model is valid. 
Solutions for the real world 
Although we cannot tell, at present, whether the use of 
chimeric activators has led to significant misundrrstand- 
ings of the molecular interactions involved in transcrip- 
tion, the problem is well worth worrying about. Only two 
specific examples have been discussed here, but in general 
all quantitative experiments will suffer from the sort of 
problems described above. The composition of purified 
preparations of chimeric activators is almost never 
reported, leading one to assume that most investigators are 
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Fig. 7. Percentage of enhancer sites occupied by D&+/ACT’ 
species for DBD-(AD), populations (solid line) compared to 
DBD-AD populations (dotted line). The graphs are calculated 
by dividing the term for DB+/ACT+ by the total number of 
DNA-binding species (DB+/ACT+ + DB+/act-1. The value of x 
(the proportion of molecules that can bind DNA) does not 
affect the graph, since molecules that do not bind DNA are 
irrelevant to this calculation. If we make the reasonable 
assumption that the activation-deficient and activation-compe- 
tent chimeras bind the enhancer with the same affinity, the 
ratio of DNA substrates occupied with DB+/ACT+ molecules to 
those with DB+/actm chimeras will directly reflect their repre- 
sentation in the protein population. 
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Fig. 8. Ratio of the fully active fraction of the DBD-CAD), popula- 
tion to the fully active fraction of the DBD-AD population over a 
range of values for y 10.01 to 1 .O). The dotted line shows the level 
above which activation is ronsidered ‘synergistic’. 
Hmv likely is it thx these problems a-t‘ real? It is, after 
all. concriv,~ble that pqantions of chimeric activators 
11~~ escccdingly lmv lr\-els of partially active species. We 
consider thi\ unlikely. In our hands only 3-20 ‘% of the 
inoleculrs in d preparation of the coinmonly ~iiiployed 
(;ALI-VI’16 chimer;1 a-e active for both I)NA md TISI’ 
binding, dependin g on the conditions employed and the 
,~ge of the prepu-ation (1:). Fancy md T.K.. unpublished 
olxervation~). These values n~ay 01. nq not prove to bc 
typic,4 for othei- chimeric dctivntors. It i5 gerierall) 
strai~:htti,i-~~~1-d to iiieasurc the fraction of l)UD+ molc- 
cules by titrating the appropriate labeled l>NA \vith n 
liiiiiting diiiount of chimer,l ‘It d concentration well 
,ibow the K,, of thr coniples. I >etermining the fixctioil 
of ,lctive Al)c is harder, md sotnt‘times impossible. If the 
asc+~ in nrhich the chimera i5 to be employed recluirec n 
discrete, measurable xtivity for the Al). cuch ‘1s TBl’ 
binding, then the fi-action of active mol~cu!e~ can be 
determined by sonit assay that accurately reflects the 
proteiIi-pi-otein inter,ictioii, for esainplr d supershift of 
the chilner,l-DNA complex upon addition of TUI’ in 
the preseiice 0f.i 1arg:r t‘scc‘ss of competitor proteins. But 
it is not cle,lr to us how 011~ would masii~w the fi-action 
of Al 1s truly competmt to activate transcription. 
If It iq found that parti,llly xtive molecules constitute a 
IJrge ciiougli fi-,lctioii of‘ the chimera population to 
complic,lte the planed esperin~ent, then the con- 
plctely active specie? mutt be purified.Thr most obvious 
\v,Iy to do this \vould be to incorporate tlic dppropriate 
affjnity clll-omntography steps in the purificCltiox proto- 
col. such ‘1s scquvnce cpecific DNA affinity chromato- 
grnphv.The problem mith this approach is that it would 
limit the amouilt of chimeric activator that could lx 
purified conveniently. Another possibility is to employ ir/ 
fGtr0 transcriptioii/tra~lslatioli to produce smdll amounts 
of protein directly. We have found that cumin GAL4 
derivatives produced in this manner have much higher 
dctivities than the corresponding sprcies purified from 
E. m/i (K. Melchers and S.A.J., unpublished obscr\.,1- 
tions). The disCldvantage of thi\ method i< that the xti- 
vator is contm~itiated nitli ii3,iii)’ other protein5 .~nd. 
qiin, only modest clmntitie7 cd11 bc obtdinc’d. It is our < 
hope thdt. oiicc the significaice of thi\ probleni ib 
Clpprrciated, more im+$nClti\~c and practic,d solutions 
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